Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
KVUE 
Kenvue Inc. (KVUE)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/17/2025: KVUE (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
19 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $19.33
1 Year Target Price $19.33
| 3 | Strong Buy |
| 2 | Buy |
| 14 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -26.2% | Avg. Invested days 23 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/17/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 33.05B USD | Price to earnings Ratio 23 | 1Y Target Price 19.33 |
Price to earnings Ratio 23 | 1Y Target Price 19.33 | ||
Volume (30-day avg) 19 | Beta 0.56 | 52 Weeks Range 13.85 - 24.41 | Updated Date 12/17/2025 |
52 Weeks Range 13.85 - 24.41 | Updated Date 12/17/2025 | ||
Dividends yield (FY) 4.78% | Basic EPS (TTM) 0.75 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9.55% | Operating Margin (TTM) 19.29% |
Management Effectiveness
Return on Assets (TTM) 6.86% | Return on Equity (TTM) 13.47% |
Valuation
Trailing PE 23 | Forward PE 15.65 | Enterprise Value 41019358283 | Price to Sales(TTM) 2.2 |
Enterprise Value 41019358283 | Price to Sales(TTM) 2.2 | ||
Enterprise Value to Revenue 2.73 | Enterprise Value to EBITDA 14.07 | Shares Outstanding 1915904828 | Shares Floating 1913560681 |
Shares Outstanding 1915904828 | Shares Floating 1913560681 | ||
Percent Insiders 0.03 | Percent Institutions 99.22 |
About Kenvue Inc.
Exchange NYSE | Headquaters Summit, NJ, United States | ||
IPO Launch date 2023-05-04 | CEO & Director Mr. Kirk L. Perry | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 22000 | Website https://www.kenvue.com |
Full time employees 22000 | Website https://www.kenvue.com | ||
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.